Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US

Complaints Against EzriCare, Delsam, Aru Pharma Follow US Warning To Manufacturer In India

Following a recall earlier in February of EzriCare’s and Delsam’s OTC artificial tears due to potential bacterial contamination, plaintiffs’ bar steps in with first of what may be multiple lawsuits. CDC says drug-resistant strain of Pseudomonas aeruginosa bacteria not previously seen in US.

• Source: Shutterstock

Less than a month after a recall of their OTC artificial tear eye drops began, EzriCare LLC and Delsam Pharma LLC are targeted in litigation alleging harm from a bacterial contamination experts say has not previously been found in the US.

More from Legal

More from Policy & Regulation